quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:49:25·44d
INSIDERFiling
Cronos Group Inc. logo

SEC Form 4 filed by Cronos Group Inc.

CRON· Cronos Group Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • CRON
    Cronos Group Inc.
    Health Care

Recent analyst ratings

  • Jan 27UpdateCanaccord Genuity-
  • Nov 2UpdateBernstein$3.00
  • Jul 28UpdateCanaccord Genuity-
  • May 11UpdateCIBC-
  • Mar 22UpdateBarclays-
  • Mar 7UpdatePiper Sandler$3.00

Related

  • PR3d
    Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026
  • INSIDER34d
    SEC Form 4 filed by Shlimak Anna
  • INSIDER37d
    Officer Doucet Terrence Gregory Joseph converted options into 23,897 shares and covered exercise/tax liability with 12,276 shares, increasing direct ownership by 12% to 105,190 units (SEC Form 4)
  • INSIDER37d
    Officer Weigensberg Arye converted options into 24,236 shares, increasing direct ownership by 13% to 208,437 units (SEC Form 4)
  • INSIDER37d
    Officer Gorenstein Michael Ryan converted options into 324,540 shares and covered exercise/tax liability with 127,706 shares, increasing direct ownership by 2% to 13,213,017 units (SEC Form 4)
  • INSIDER37d
    Officer Shlimak Anna converted options into 45,226 shares and covered exercise/tax liability with 16,354 shares, increasing direct ownership by 9% to 339,933 units (SEC Form 4)
  • INSIDER37d
    Chief Growth Officer Jacobson Jeffrey David converted options into 59,191 shares and covered exercise/tax liability with 22,552 shares, increasing direct ownership by 8% to 484,681 units (SEC Form 4)
  • INSIDER37d
    Officer Buggy Shannon covered exercise/tax liability with 9,202 shares and converted options into 20,938 shares, increasing direct ownership by 8% to 166,879 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022